Tag: FDA

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
11 January 2026

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The FDA's Purple Book is the official source for information on biosimilars and interchangeable biological products. Learn how it works, what interchangeability really means, and why it matters for patients and providers.

Read More